Table 1.
Rheumatologic disease | Age | Sex | Treatment | Time | Outcome evolution | Author, year |
---|---|---|---|---|---|---|
Ankylosing spondylitis | 55 | M | Corticoid | — | Survived | Beasley et al., 2002, [1] |
Polymyositis | 78 | F | Corticoid | — | Death | Beasley et al., 2002, [1] |
Fibromyalgia | 58 | F | Antibiotic | — | Survived | Beasley et al., 2002, [1] |
Juvenile dermatomyositis | 14 | F | Azithromycin, immunoglobulin, cyclophosphamide, methylprednisolone, and cyclosporine | 2 months | Death | Prahalad et al., 2005, [12] |
Stigma of rheumatic disease | 47 | M | Prednisone | 3 months | Survived | Balduin et al., 2007, [13] |
SLE and APS | 16 | M | Prednisone, cyclophosphamide, anticoagulants | 2,5 months | Survived | Hariri et al., 2010, [14] |
SLE: systemic erythematosus lupus; APS: antiphospholipid syndrome.